Saneesh PS, Morampudi SC, Yelamanchi R. Radiological review of rhinocerebral mucormycosis cases during the COVID-19 Pandemic: A single-center experience. World J Radiol 2022; 14(7): 209-218 [PMID: 36160626 DOI: 10.4329/wjr.v14.i7.209]
Corresponding Author of This Article
Raghav Yelamanchi, DNB, MS, Surgeon, Surgical Oncologist, Department of Surgery, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Delhi 110001, Delhi, India. raghavyelamanchi@gmail.com
Research Domain of This Article
Radiology, Nuclear Medicine & Medical Imaging
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Radiol. Jul 28, 2022; 14(7): 209-218 Published online Jul 28, 2022. doi: 10.4329/wjr.v14.i7.209
Radiological review of rhinocerebral mucormycosis cases during the COVID-19 Pandemic: A single-center experience
P S Saneesh, Satya Chowdary Morampudi, Raghav Yelamanchi
P S Saneesh, Department of Radiology, Aster MIMS, Kannur 670007, Kerala, India
Satya Chowdary Morampudi, Department of Radiodiagnosis, Pinnamaneni Siddhartha Institute of Medical Sciences & Research Foundation, Gannavaram 521101, Andhra Pradesh, India
Raghav Yelamanchi, Department of Surgery, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Delhi 110001, Delhi, India
Author contributions: Saneesh PS analyzed the data; Morampudi SC analyzed the data and wrote the manuscript; Yelamanchi R analyzed the data and wrote the manuscript; All authors have read and approved the final manuscript.
Conflict-of-interest statement: None of the authors in the study have any conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Raghav Yelamanchi, DNB, MS, Surgeon, Surgical Oncologist, Department of Surgery, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Delhi 110001, Delhi, India. raghavyelamanchi@gmail.com
Received: March 28, 2022 Peer-review started: March 28, 2022 First decision: May 12, 2022 Revised: June 9, 2022 Accepted: July 18, 2022 Article in press: July 18, 2022 Published online: July 28, 2022
Core Tip
Core Tip: Rhinocerebral mucormycosis constituted the aftermath of the coronavirus disease 2019 pandemic, leading to rapid increase in the number of cases, which were previously restricted only to few susceptible groups of patients. Rhinocerebral mucormycosis is associated with high mortality and morbidity. After clinical examination, imaging is the backbone for the diagnosis of this severe disease. Computed tomography helps in the preliminary diagnosis and helps to stage the disease. However, when orbital and intracranial extension is present, magnetic resonance imaging (MRI) is preferred because it delineates the involvement of these structures better. MRI can also delineate vascular involvement better. This article reviews the various imaging findings of mucormycosis.
